AARTI PHARMALABS
Back to Balance Sheet
|
AARTI PHARMALABS Last 5 Year Total Current Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|
Total Current Liabilities | ₹694 Cr | ₹601 Cr | ₹581 Cr | ₹0.02 Cr |
What is the latest Total Current Liabilities ratio of AARTI PHARMALABS ?
Year | Total Current Liabilities |
---|---|
Mar2024 | ₹694 Cr |
Mar2023 | ₹601 Cr |
Mar2022 | ₹581 Cr |
Mar2021 | ₹0.02 Cr |
How is Total Current Liabilities of AARTI PHARMALABS Trending?
Years | Total Current Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹694 Cr | 15.61 | |
Mar2023 | ₹601 Cr | 3.44 | |
Mar2022 | ₹581 Cr | 2,639,286.36 | |
Mar2021 | ₹0.02 Cr | - |
Compare Total Current Liabilities of peers of AARTI PHARMALABS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
AARTI PHARMALABS | ₹8,061.1 Cr | 1.1% | 25.8% | 59.4% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹401,865.0 Cr | -0.5% | -8.4% | 14.6% | Stock Analytics | |
DIVIS LABORATORIES | ₹173,574.0 Cr | -2.4% | 7.2% | 50.6% | Stock Analytics | |
CIPLA | ₹118,710.0 Cr | -0.7% | -3.7% | -1% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹105,964.0 Cr | -1.4% | -3.9% | 19% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹104,232.0 Cr | 0.5% | 5.6% | 5.1% | Stock Analytics |
AARTI PHARMALABS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
AARTI PHARMALABS | 1.1% |
25.8% |
59.4% |
SENSEX | -1% |
1.4% |
7.9% |
You may also like the below Video Courses